For the third quarter of fiscal 2025, the company expects revenues of $4.65 billion (+/- $300 million). The Zacks Consensus Estimate is pegged at $4.64 billion, indicating 22.3% growth from the figure ...
Lockdowns, lab closures, funding cuts, and delays to ongoing clinical trials have all contributed to cancer research disruptions that may set the field back two years, according to new estimates made ...
Here’s the gist: Goal-setting restructures your brain to make it more effective. A key article in Behavioral and Cognitive Neuroscience Reviews explains: First, emotional significance is evaluated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback